A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 2, 2007, Pages 312-317

  Reinders, Mattheus K ^a,b   Nijdam, Lars C ^b   van Roon, Eric N ^a,b   Movig, Kris L L ^c   Jansen, Tim L Th A ^a   van de Laar, Mart A F J ^d   Brouwers, Jacobus R B J ^a,b  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Allopurinol; Oxipurinol; Reversed phase chromatography; Stability; Validation

Indexed keywords

ACETIC ACID; ACICLOVIR; ALLOPURINOL; DICHLOROMETHANE; OXIPURINOL;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; FLOW RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STANDARD; ULTRAVIOLET SPECTROSCOPY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALLOPURINOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OXYPURINOL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SODIUM ACETATE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 34848851090     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.08.002     Document Type: Article

References (26)

1. Pea F. Contrib. Nephrol. 147 (2005) 35-46
2. Reiter S., Simmonds H.A., Zöllner N., et al. Clin. Chim. Acta 187 (1990) 221-234
3. Hande K.R., Noone R.M., and Stone W.J. Am. J. Med. 76 (1984) 47-56
4. Perez-Ruiz F., Hernando I., Villar I., et al. J. Clin. Rheumatol. 11 (2005) 129-133
5. ®. Http://www.cbg-meb.nl/nl/prodinfo/index.htm; March 30th, 2007.
6. Takada M., Okada H., Kotake T., et al. J. Clin. Pharm. Ther. 30 (2005) 407-412
7. Day R.O., Miners J.O., Birkett D.J., et al. Br. J. Clin. Pharmacol. 26 (1988) 423-428
8. Peterson G.M., Boyle R.R., Francis H.W., et al. Eur. J. Clin. Pharmacol. 39 (1990) 419-421
9. Hande K., Reed E., and Chabner B. Clin. Pharmacol. Ther. 23 (1978) 598-605
10. Yamamoto T., Moriwaki Y., Takahashi S., et al. Ann. Rheum. Dis. 50 (1991) 631-633
11. Iwanaga T., Kobayashi D., Hirayama M., et al. Drug Metab. Dispos. 33 (2005) 1791-1795
12. Riedel A.A., Nelson M., Joseph-Ridge N., et al. J. Rheumatol. 31 (2004) 1575-1581
13. Stamp L., Gow P., Sharples K., et al. Aust. N. Z. J. Med. 30 (2000) 567-572
14. Tada H., Fujisaki A., Itoh K., et al. J. Clin. Pharm. Ther. 28 (2003) 229-234
15. de Vries J.X., Voss A., Kutschker C., et al. Arzneimittelforschung 43 (1993) 1072-1075
16. Kojima T., Nishina T., Kitamura M., et al. Clin. Chem. 32 (1986) 287-290
17. Failler J.M., Farinotti R., and Dauphin A. Ther. Drug Monit. 7 (1985) 324-328
18. Boulieu R., Bory C., Baltassat P., et al. J. Chromatogr. 307 (1984) 469-474
19. Nissen P. J. Chromatogr. 228 (1982) 382-386
20. Breithaupt H., and Goebel G. J. Chromatogr. 226 (1981) 237-242
21. Wung W.E., and Howell S.B. Clin. Chem. 26 (1980) 1704-1708
22. Kramer W.G., and Feldman S. J. Chromatogr. 162 (1979) 94-97
23. The European Agency for the Evaluation of Medicinal Products, Note for guidance on validation of analytical procedures (CPMP/ICH/281/95), Http://www.emea.eu.int/pdfs/human/ich/028195en.pdf (March 30th, 2007).
24. Food and Drug Administration, Guidance for Industry Bioanalytical Method Validation, May 2001, Http://www.fda.gov/cder/guidance/4252fnl.pdf (March 30th, 2007).
25. Tsouli S.G., Liberopoulos E.N., Mikhailidis D.P., et al. Metabolism 55 (2006) 1293-1301
26. Chang S.L., and Kramer W.G. J. Chrom. 181 (1980) 286